← Leaderboards
Gerardo Gonzalez
Yale University
$6,578,328
Attributed
$16,117,847
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,117,847 · 5
By mechanism
R01$15,188,921 · 3
P50$652,022 · 1
K23$276,904 · 1
Top collaborators
- Wenjun Li5 shared
- Todd Alden Olmstead5 shared
- David A Smelson5 shared
Most similar at Yale University
Same institution · by research overlap
- Thomas Richard Kosten$19,160,340
- Alison Oliveto Beaudoin$13,435,140
- Angelique Bordey$13,044,438
- George B Richerson$18,281,692
- Robert T Malison$17,226,399
Others in their field
Top investigators on “Patient Self-Report”
- David R. Weir · University Of Michigan At Ann Arbor$82,494,797
- Judith Kasper · Johns Hopkins University$59,756,567
- Linda J Waite · University Of Chicago$34,575,180
- Lloyd D Johnston · University Of Michigan At Ann Arbor$32,190,173
- David Cella · Evanston Northwestern Healthcare Res Ins$29,995,323
- Peter J. Snyder · University Of Pennsylvania$28,513,029
Research focus
Patient Self-ReportRandomizedParticipantRelapseDesignOpioidPsychosocialCombination MedicationSeveritiesAddictionOpiate AddictionGroup TherapyInnovationBaseMedicalUptakeSymptomsBehavior TherapyClinical TrialsPharmaceutical PreparationsMethadoneCommunity ServicesCommunitiesComplex
Grant awards (17)
Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)$2,587,255
R01 · FY2024 · MH
Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)$3,467,847
R01 · FY2023 · MH
Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)$3,300,824
R01 · FY2022 · MH
Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)$208,234
R01 · FY2022 · MH
Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)$3,155,199
R01 · FY2021 · MH
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults$395,429
R01 · FY2011 · DA · contact PI
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults$400,742
R01 · FY2010 · DA · contact PI
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults$417,615
R01 · FY2009 · DA · contact PI
Tiagabine for Cocaine Dependence in Methadone Treatment$305,210
R01 · FY2007 · DA · contact PI
Tiagabine for Cocaine Dependence in Methadone Treatment$310,443
R01 · FY2006 · DA · contact PI
Tiagabine and Disulfiram for Cocaine Dependence$257,929
P50 · FY2006 · DA · contact PI
Tiagabine for Cocaine Dependence in Methadone Treatment$318,039
R01 · FY2005 · DA
Tiagabine and Disulfiram for Cocaine Dependence$215,275
P50 · FY2005 · DA
Comorbid Disorders in Treatment of Opiate Dependence$137,283
K23 · FY2005 · DA
Tiagabine for Cocaine Dependence in Methadone Treatment$322,084
R01 · FY2004 · DA
Tiagabine and Disulfiram for Cocaine Dependence$178,818
P50 · FY2004 · DA
Comorbid Disorders in Treatment of Opiate Dependence$139,621
K23 · FY2004 · DA